China Oncology ›› 2024, Vol. 34 ›› Issue (6): 571-580.doi: 10.19401/j.cnki.1007-3639.2024.06.005
• Article • Previous Articles Next Articles
CHEN Xun(), ZHENG Zhenxia, RUAN Xueru(
)(
)
Received:
2023-11-15
Revised:
2024-06-16
Online:
2024-06-30
Published:
2024-07-16
Contact:
RUAN Xueru
E-mail:ruanxueru@163.com
Share article
CLC Number:
CHEN Xun, ZHENG Zhenxia, RUAN Xueru. Effects of TMCO1 on proliferation and migration of cervical cancer cells[J]. China Oncology, 2024, 34(6): 571-580.
Fig. 2
Overexpression of TMCO1 promotes the proliferation of cervical cancer HeLa cells A: A TMCO1 lentiviral expression vector was infected with the cervical cancer cell line HeLa to obtain a cell line stably expressing TMCO1. The cell line infected with the EV was used as a control, and the expression of TMCO1 was confirmed by IB. B: The stably transfected TMCO1 cells and control cells (EV) were subjected to CCK-8 cell proliferation assay. C, D: The stably transfected TMCO1 cells and control cells (EV) were seeded into 6-well plates at 1 000 cells/well, and the number of clones formed was counted after 10 days of culture. E, F: The stably transfected TMCO1 cells and control cells (EV) were labeled with EdU to detect the number of cells undergoing active DNA synthesis. *: P<0.05, **: P<0.01. EV: Empty vector."
Fig. 3
Knocking down TMCO1 inhibited the proliferation of cervical cancer HeLa cells A: Two independent shRNAs targeting the TMCO1 gene sequence were designed and cloned into the pLKO.1 lentiviral vector, which was used to infect the cervical cancer cell line HeLa. After puromycin selection, cells with stable knockdown of TMCO1 were obtained, and cells infected with the empty vector (pLKO.1) virus were used as controls. The cells were collected and the knockdown of TMCO1, as well as the phosphorylation of cell cycle inhibitory protein p27 and histone H3 were detected by IB. B, C: The above TMCO1 stable knockdown cells and control cells were seeded into 6-well plates at 1 000 cells/well, and the number of clones formed was counted after 10 days of culture. D, E: The above TMCO1 stable knockdown cells and control cells were EdU labeled to detect the number of cells undergoing active DNA synthesis. *: P<0.05, **: P<0.01, ***: P<0.001, compared with empty vector (pLKO.1)."
Fig. 4
TMCO1 promoted the migration of cervical cancer HeLa cells A, B: The stably transfected TMCO1 cells and control cells (EV) obtained in Figure 2 were inoculated into chambers according to the experimental steps for transwell cell migration assay. After 24 hours, the cells were fixed with formaldehyde and stained with crystal violet, and the number of migrated cells was observed and photographed under a microscope and the number of migrated cells was counted. C, D: The TMCO1 stable knockdown cells and control cells (pLKO.1) in Figure 3 were inoculated into the chamber according to the experimental steps for the transwell cell migration experiment. After 24 hours, the cells were fixed with formaldehyde and stained with crystal violet. The number of migrated cells was observed and photographed under a microscope, and the number of migrated cells was counted. ***: P <0.001, compared with empty vector (EV or pLKO.1)."
Fig. 5
TMCO1 regulated cell adhesion and signaling transduction A: The Flag-TMCO1 cells and control cells (EV) in Figure 2 were collected, cell lysates were prepared and trypsinized, and then analyzed by liquid chromatography-tandem mass spectrometry. Data were collected for principal component analysis, and it can be seen that the two Flag-TMCO1 stable expression cell line samples and the three control cell (EV) samples were clustered together, indicating that the stable expression of TMCO1 caused significant changes in the proteomic level. B: The differentially expressed proteins obtained by quantitative analysis of the protein expression profile data obtained in (A) were analyzed and a volcano plot was drawn, and representative proteins with significant differences were annotated. C, D: GSEA-KEGG pathway enrichment analysis was performed on the differentially expressed proteins in the Flag-TMCO1 stable expression cells and control cells (EV) protein expression groups, showing that pathways related to extracellular matrix-adhesion and PI3K-AKT signaling were significantly upregulated in Flag-TMCO1 stable expression cells, while ribosome-related pathways were downregulated."
[1] | JEMAL A, SIEGEL R, XU J Q, et al. Cancer statistics. Ca cancer J clin[J]. CA A Cancer J Clin, 2010, 60(5): 277-300. |
[2] | SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1): 7-30. |
[3] | CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J, 2021, 134(7): 783-791. |
[4] | GROENENDYK J, MICHALAK M. Interplay between calcium and endoplasmic reticulum stress[J]. Cell Calcium, 2023, 113: 102753. |
[5] | LI W, OUYANG Z, ZHANG Q, et al. SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2[J]. Cell Death Dis, 2014, 5(12): e1581. |
[6] | WANG Q C, ZHENG Q X, TAN H Y, et al. TMCO1 is an ER Ca(2+) load-activated Ca(2+) channel[J]. Cell, 2016, 165(6): 1454-1466. |
[7] | ZHANG N N, TANG M, WEN M R, et al. Expression, purification and characterization of TMCO1 for structural studies[J]. Protein Expr Purif, 2021, 179: 105803. |
[8] | SUN Z S, ZHANG H, WANG X, et al. TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells[J]. Cell Death Differ, 2018, 25(9): 1686-1701. |
[9] | LI J W, LIU C Z, LI Y H, et al. TMCO1-mediated Ca2+ leak underlies osteoblast functions via CaMKⅡ signaling[J]. Nat Commun, 2019, 10(1): 1589. |
[10] | BATCHELOR-REGAN H, XIN B Z, ZHOU A M, et al. From disease description and gene discovery to functional cell pathway: a decade-long journey for TMCO1[J]. Front Genet, 2021, 12: 652400. |
[11] | ZHENG S L, WANG X W, ZHAO D, et al. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications[J]. Trends Cell Biol, 2023, 33(4): 312-323. |
[12] |
YANG X, ZHUANG J, SONG W L, et al. Mitochondria-associated endoplasmic reticulum membrane: overview and inextricable link with cancer[J]. J Cell Mol Med, 2023, 27(7): 906-919.
doi: 10.1111/jcmm.17696 pmid: 36852470 |
[13] | LI C F, WU W R, CHAN T C, et al. Transmembrane and coiled-coil domain 1 impairs the AKT signaling pathway in urinary bladder urothelial carcinoma: a characterization of a tumor suppressor[J]. Clin Cancer Res, 2017, 23(24): 7650-7663. |
[14] | ZHENG S L, ZHAO D, HOU G X, et al. iASPP suppresses Gp78-mediated TMCO1 degradation to maintain Ca2+ homeostasis and control tumor growth and drug resistance[J]. Proc Natl Acad Sci U S A, 2022, 119(6): e2111380119. |
[15] | GAO L, YE Z, LIU J H, et al. TMCO1 expression promotes cell proliferation and induces epithelial-mesenchymal transformation in human gliomas[J]. Med Oncol, 2022, 39(5): 90. |
[16] | YANG C, WANG Y, BAI J Q, et al. Mechanism of transmembrane and coiled-coil domain 1 in the regulation of proliferation and migration of A549 cells[J]. Oncol Lett, 2020, 20(5): 159. |
[17] | SUN G Y, GONG S, LAN S W, et al. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance[J]. Cell Mol Biol, 2024, 70(1): 99-109. |
[18] | 殷苏威, 张裕民, 郭丽, 等. Irisin通过PI3K/AKT/Cyclin D1途径促进宫颈癌HeLa细胞增殖的机制研究[J]. 中国计划生育和妇产科, 2022, 14(5): 100-105. |
YIN S W, ZHANG Y M, GUO L, et al. The mechanism research of Irisin promoting the proliferation of cervical cancer HeLa cells through PI3K/AKT/Cyclin D1 pathway[J]. Chin J Fam Plan Gynecotokol, 2022, 14(5): 100-105. | |
[19] | CHEN L, LIU D M, YI X F, et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway[J]. Cell Death Dis, 2020, 11(5): 320. |
[20] | DAI B L, YU R Z, FAN M Y, et al. HMQ-T-F2 suppresses migration of the human cervical cancer HeLa cells by reversing EMT via the PI3K/Akt signaling pathway[J]. Oncol Rep, 2019, 42(4): 1451-1458. |
[21] |
PELLETIER J, THOMAS G, VOLAREVIĆ S. Ribosome biogenesis in cancer: new players and therapeutic avenues[J]. Nat Rev Cancer, 2018, 18(1): 51-63.
doi: 10.1038/nrc.2017.104 pmid: 29192214 |
[22] |
PRAKASH V, CARSON B B, FEENSTRA J M, et al. Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease[J]. Nat Commun, 2019, 10(1): 2110.
doi: 10.1038/s41467-019-10100-8 pmid: 31068593 |
[23] | KUDO M, ANAM M B, ISTIAQ A, et al. Ribosome incorporation induces EMT-like phenomenon with cell cycle arrest in human breast cancer cell[J]. Cells Tissues Organs, 2022, 211(2): 212-221. |
[1] | WEN Ziqiang, LAN Junliang, ZHOU Bo, XU Qiwei. PARP1 promotes the progression of hepatocellular carcinoma by regulating expression of POU2F2 [J]. China Oncology, 2024, 34(9): 848-856. |
[2] | CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong. Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma [J]. China Oncology, 2024, 34(8): 753-762. |
[3] | SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying. Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells [J]. China Oncology, 2024, 34(5): 439-450. |
[4] | XIONG Jiayan, LEI Wei, YOU Bo, ZHANG Zhenxin, XIE Haijing, SHAN Ying, XIA Tian, ZHOU Yong. Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA [J]. China Oncology, 2024, 34(5): 451-459. |
[5] | ZHOU Xueqin, LUAN Yanchao, ZHAO Li, RONG Chaochao, YANG Na. Expression of CDC20 in lung adenocarcinoma tissues and its effect on the proliferation and invasion of lung adenocarcinoma cells [J]. China Oncology, 2024, 34(5): 460-472. |
[6] | GUAN Ruirui, HAO Qian, ZHANG Yaqi, SUN Qinggang, CHEN Yitian, LI Xiumin, ZHOU Xiang, HAN Tao. CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression [J]. China Oncology, 2024, 34(5): 473-484. |
[7] | FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao. Progress in treatment of gynecological cancer in 2023 [J]. China Oncology, 2024, 34(4): 340-360. |
[8] | SHEN Jie, FENG Xiaoshuang, WEN Hao, ZHOU Changming, MO Miao, WANG Zezhou, YUAN Jing, WU Xiaohua, ZHENG Ying. Metastasis patterns and survival analysis of 572 patients with metastatic cervical cancer: a hospital-based real world study [J]. China Oncology, 2024, 34(4): 361-367. |
[9] | XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou. Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions [J]. China Oncology, 2024, 34(11): 998-1010. |
[10] | JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan. Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma [J]. China Oncology, 2023, 33(8): 717-725. |
[11] | WANG Xuemei, CHENG Yu, QI Jiemin. PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway [J]. China Oncology, 2023, 33(5): 437-444. |
[12] | ZHANG Pingchuan, DU Mingyu, YAO Chengyun, HE Xia, YIN Li. Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior [J]. China Oncology, 2023, 33(5): 445-451. |
[13] | XIAO Lanshu, PAN Liudi, LIU Yi, WANG Jie, CHEN Hui. LncRNA DLEU7-AS1 contributes to proliferation and migration of gastric cancer by regulating MSN transcription [J]. China Oncology, 2023, 33(4): 327-341. |
[14] | CHEN Hong, CHEN Junxia. Effect of hsa_circ_0001573 on biological behaviors of breast cancer cells and its molecular mechanism [J]. China Oncology, 2023, 33(4): 342-353. |
[15] | PENG Jin, WANG Weining, TAN Zhi, YE Guannan, ZHOU Zhen. The mechanism of m6Am-modifying enzyme PCIF1 regulating target gene ACOT8 in gastric cancer progression [J]. China Oncology, 2023, 33(4): 368-376. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd